Propanc Biopharma, Inc. (PPCB) Net Income by Year
Propanc Biopharma, Inc. reported a net loss of $58.9M in fiscal year 2025. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Propanc Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PPCB Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
PPCB Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Propanc Biopharma, Inc. financials
Frequently Asked Questions
What was Propanc Biopharma, Inc.'s net income in fiscal year 2025?
Propanc Biopharma, Inc. reported a net loss of $58.9M in fiscal year 2025.
How has Propanc Biopharma, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Propanc Biopharma, Inc. (PPCB) net income went from -$2.2M in fiscal year 2011 to -$58.9M in fiscal year 2025.
What was Propanc Biopharma, Inc.'s net income in the most recent quarter?
Propanc Biopharma, Inc. (PPCB) reported -$6.4M in net income in Q3 2026. This represents an increase of 88.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Propanc Biopharma, Inc. (PPCB) reported on that line in every period on record.